| Year |
Citation |
Score |
| 2020 |
Zhou H, Blevins MA, Hsu JY, Kong D, Galbraith MD, Goodspeed A, Culp-Hill R, Oliphant MU, Ramirez D, Zhang L, Pineiro JT, Mathews Griner L, King R, Barnaeva E, Hu X, et al. A SIX1/EYA2 small molecule inhibitor disrupts EMT and metastasis. Cancer Research. PMID 32341035 DOI: 10.1158/0008-5472.Can-20-0435 |
0.471 |
|
| 2020 |
Zhou H, Blevins M, Kong D, Hsu J, Galbraith M, Goodspeed A, Culp-Hill R, Oliphant M, Ramirez D, Gustafson D, D'Alessandro A, Costello J, Patnaik S, Marugan J, Zhao R, et al. Novel Small Molecule Compound disrupts the SIX1/EYA2 Complex and Inhibits Breast Cancer Metastasis The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02458 |
0.443 |
|
| 2019 |
Anantharajan J, Zhou H, Zhang L, Hotz T, Vincent MY, Blevins MA, Jansson AE, Liang Kuan JW, Ng EY, Yeo K, Baburajendran N, Lin G, Hung AW, Joy J, Patnaik S, et al. Structural and functional analyses of an allosteric Eya2 phosphatase inhibitor that has on target effects in human lung cancer cells. Molecular Cancer Therapeutics. PMID 31285279 DOI: 10.1158/1535-7163.Mct-18-1239 |
0.419 |
|
| 2019 |
Zhou H, Blevins M, Zhang L, Kong D, Oliphant M, Gustafson DL, Patnaik S, Marugan J, Zhao R, Ford HL. Abstract 2004: Identification of a novel small molecule inhibitor of the Six1/Eya2 complex andin vivometastasis Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2004 |
0.339 |
|
| 2017 |
Blevins MA, Huang M, Zhao R. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target. Molecular Cancer Therapeutics. 16: 981-990. PMID 28576945 DOI: 10.1158/1535-7163.MCT-16-0592 |
0.343 |
|
| 2015 |
Blevins MA, Towers CG, Patrick AN, Zhao R, Ford HL. The SIX1-EYA transcriptional complex as a therapeutic target in cancer. Expert Opinion On Therapeutic Targets. 19: 213-25. PMID 25555392 DOI: 10.1517/14728222.2014.978860 |
0.428 |
|
| 2015 |
Blevins MA, Kouznetsova J, Krueger AB, King R, Griner LM, Hu X, Southall N, Marugan JJ, Zhang Q, Ferrer M, Zhao R. Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression. Journal of Biomolecular Screening. 20: 663-72. PMID 25477201 DOI: 10.1177/1087057114561400 |
0.451 |
|
| 2014 |
Krueger AB, Drasin DJ, Lea WA, Patrick AN, Patnaik S, Backos DS, Matheson CJ, Hu X, Barnaeva E, Holliday MJ, Blevins MA, Robin TP, Eisenmesser EZ, Ferrer M, Simeonov A, et al. Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration. The Journal of Biological Chemistry. 289: 16349-61. PMID 24755226 DOI: 10.1074/Jbc.M114.566729 |
0.479 |
|
| 2013 |
Patrick A, Blevins M, Krueger A, Cabrera J, Backos D, Reigan P, Zhao R, Ford H. Abstract B102: Targeting the SIX1/EYA transcriptional complex as a potential anti-cancer therapy. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B102 |
0.482 |
|
| 2011 |
Blevins M, An J, Jones S, Swaroop M, Ferrer M, Ford H, Zhao R. Abstract 1373: Identification of potential anti-tumor therapeutics targeting the Six1 transcriptional complex Cancer Research. 71: 1373-1373. DOI: 10.1158/1538-7445.Am2011-1373 |
0.473 |
|
| Show low-probability matches. |